MAIN CONTENT
A nomination ends before the decisive vote
The administration withdrew Overton's nomination on November 17, ahead of the November 18 vote scheduled in the Senate Health, Education, Labor and Pensions Committee, according to the Associated Press. Its Republican chairman, physician Bill Cassidy of Louisiana, had publicly withheld a commitment to support her. Republicans held 12 committee seats to Democrats' 11, leaving little margin for dissent if the Democrats opposed the nomination together.
The retreat was a political assessment rather than a recorded defeat in committee. Reuters separately reported that insufficient congressional backing prompted the move. The calendar amplified the problem: Republicans were trying to confirm outstanding nominees before Democrats assumed control of the Senate in January. A nomination that could not clear the committee risked running out of time entirely.
Vaccination policy becomes the test of independence
Nominated in August, Overton had been presented as someone who could steady the FDA after a turbulent period. At her September 24 hearing, however, senators from both parties questioned her role in changing childhood immunization recommendations.

















